Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Blockade of CD14 aggravates experimental shigellosis.

Wennerås C, Ave P, Huerre M, Arondel J, Ulevitch R, Mathison J, Sansonetti P.

J Endotoxin Res. 2001;7(6):442-6.

PMID:
11753214
2.

Parameters underlying successful protection with live attenuated mutants in experimental shigellosis.

Bernardini ML, Arondel J, Martini I, Aidara A, Sansonetti PJ.

Infect Immun. 2001 Feb;69(2):1072-83.

3.

Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation.

Sansonetti PJ, Phalipon A, Arondel J, Thirumalai K, Banerjee S, Akira S, Takeda K, Zychlinsky A.

Immunity. 2000 May;12(5):581-90.

4.

Blockade of CD14 increases Shigella-mediated invasion and tissue destruction.

Wennerås C, Ave P, Huerre M, Arondel J, Ulevitch RJ, Mathison JC, Sansonetti P.

J Immunol. 2000 Mar 15;164(6):3214-21.

5.

Increased interleukin-1 (IL-1) and imbalance between IL-1 and IL-1 receptor antagonist during acute inflammation in experimental Shigellosis.

Arondel J, Singer M, Matsukawa A, Zychlinsky A, Sansonetti PJ.

Infect Immun. 1999 Nov;67(11):6056-66.

6.

Interleukin-8 controls bacterial transepithelial translocation at the cost of epithelial destruction in experimental shigellosis.

Sansonetti PJ, Arondel J, Huerre M, Harada A, Matsushima K.

Infect Immun. 1999 Mar;67(3):1471-80.

7.

Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB.

Hilbi H, Moss JE, Hersh D, Chen Y, Arondel J, Banerjee S, Flavell RA, Yuan J, Sansonetti PJ, Zychlinsky A.

J Biol Chem. 1998 Dec 4;273(49):32895-900.

8.

Immunogenicity of IpaC-hybrid proteins expressed in the Shigella flexneri 2a vaccine candidate SC602.

Bârzu S, Arondel J, Guillot S, Sansonetti PJ, Phalipon A.

Infect Immun. 1998 Jan;66(1):77-82.

9.

Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics.

Phalipon A, Folgori A, Arondel J, Sgaramella G, Fortugno P, Cortese R, Sansonetti PJ, Felici F.

Eur J Immunol. 1997 Oct;27(10):2620-5.

PMID:
9368618
10.

In vivo apoptosis in Shigella flexneri infections.

Zychlinsky A, Thirumalai K, Arondel J, Cantey JR, Aliprantis AO, Sansonetti PJ.

Infect Immun. 1996 Dec;64(12):5357-65.

11.
12.

Role of interleukin-1 in the pathogenesis of experimental shigellosis.

Sansonetti PJ, Arondel J, Cavaillon JM, Huerre M.

J Clin Invest. 1995 Aug;96(2):884-92.

13.

Identification and characterization of B-cell epitopes of IpaC, an invasion-associated protein of Shigella flexneri.

Phalipon A, Arondel J, Nato F, Rouyre S, Mazie JC, Sansonetti PJ.

Infect Immun. 1992 May;60(5):1919-26.

14.
15.

Construction and evaluation of live attenuated vaccine strains of Shigella flexneri and Shigella dysenteriae 1.

Fontaine A, Arondel J, Sansonetti PJ.

Res Microbiol. 1990 Sep-Oct;141(7-8):907-12.

PMID:
2101481
16.

Contribution of superoxide dismutase and catalase activities to Shigella flexneri pathogenesis.

Franzon VL, Arondel J, Sansonetti PJ.

Infect Immun. 1990 Feb;58(2):529-35.

18.

Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor.

Nassif X, Fournier JM, Arondel J, Sansonetti PJ.

Infect Immun. 1989 Feb;57(2):546-52.

19.
20.

Possible role of a defect in hepatic bilirubin glucuronidation in the initiation of cholesterol gallstones.

Duvaldestin P, Mahu JL, Metreau JM, Arondel J, Preaux AM, Berthelot P.

Gut. 1980 Aug;21(8):650-5.

21.

Uptake of rifampicin by isolated rat liver cells. Interaction with sulfobromophthalein uptake and evidence for separate carriers.

Laperche Y, Graillot C, Arondel J, Berthelot P.

Biochem Pharmacol. 1979 Jul 1;28(13):2065-9. No abstract available.

PMID:
475848
22.

[Effect of spironolactone on bile formation and liver microsomal enzymic activities in the rat (author's transl)].

Miguet JP, Mavier P, Arondel J, Preaux AM, Dhumeaux D.

Gastroenterol Clin Biol. 1977;1(12):1007-13. French. No abstract available.

PMID:
606621

Supplemental Content

Loading ...
Support Center